Search inside SEC filings
Every 10-K, 10-Q, 8-K, proxy and registration statement filed since 2001, searched by what the text actually says. Free, no account, straight through to the document.
At least 10,000 filings contain "REGENERON"
showing the first 40- Kiniksa Pharmaceuticals, Ltd. (KNSA)10-Q · 2021-05-06Read the filing on SEC.gov →
- Angion Biomedica Corp. (ELTX)S-4/A · 2023-03-29Read the filing on SEC.gov →
- Intellia Therapeutics, Inc. (NTLA)8-K · 2020-06-01Read the filing on SEC.gov →
- REGENERON PHARMACEUTICALS, INC. (REGN)10-Q · 2020-11-05Read the filing on SEC.gov →
- Sanofi6-K · 2020-05-07Read the filing on SEC.gov →
- Sanofi6-K · 2022-01-24Read the filing on SEC.gov →
- Sanofi6-K · 2025-12-23Read the filing on SEC.gov →
- Checkmate Pharmaceuticals, Inc.SC14D9C · 2022-04-20Read the filing on SEC.gov →
- Sanofi6-K · 2025-09-22Read the filing on SEC.gov →
- Intellia Therapeutics, Inc. (NTLA)S-1/A · 2016-04-27Read the filing on SEC.gov →
- Sanofi6-K · 2025-12-03Read the filing on SEC.gov →
- REGENERON PHARMACEUTICALS, INC. (REGN)10-Q · 2023-08-03Read the filing on SEC.gov →
- REGENERON PHARMACEUTICALS INC (REGN)10-K · 2007-03-12Read the filing on SEC.gov →
- Sanofi6-K · 2024-05-28Read the filing on SEC.gov →
- Checkmate Pharmaceuticals, Inc.SC14D9C · 2022-04-20Read the filing on SEC.gov →
- OCULAR THERAPEUTIX, INC (OCUL)10-Q · 2016-11-09Read the filing on SEC.gov →
- REGENERON PHARMACEUTICALS INC (REGN)10-Q · 2015-05-07Read the filing on SEC.gov →
- Decibel Therapeutics, Inc.SC14D9C · 2023-08-09Read the filing on SEC.gov →
- Intellia Therapeutics, Inc. (NTLA)S-1/A · 2016-05-05Read the filing on SEC.gov →
- Sanofi6-K · 2021-08-09Read the filing on SEC.gov →
- Intellia Therapeutics, Inc. (NTLA)8-K · 2020-06-01Read the filing on SEC.gov →
- Decibel Therapeutics, Inc.SC14D9C · 2023-08-09Read the filing on SEC.gov →
- Sanofi6-K · 2022-04-07Read the filing on SEC.gov →
- Intellia Therapeutics, Inc. (NTLA)S-1/A · 2016-04-12Read the filing on SEC.gov →
- MAIA Biotechnology, Inc. (MAIA)S-1 · 2022-04-11Read the filing on SEC.gov →
- Sanofi6-K · 2020-04-29Read the filing on SEC.gov →
- Decibel Therapeutics, Inc.SC14D9C · 2023-08-09Read the filing on SEC.gov →
- Intellia Therapeutics, Inc. (NTLA)10-Q · 2022-05-05Read the filing on SEC.gov →
- Checkmate Pharmaceuticals, Inc.8-K · 2022-04-19Read the filing on SEC.gov →
- Sanofi6-K · 2021-06-30Read the filing on SEC.gov →
- Intellia Therapeutics, Inc. (NTLA)10-Q · 2023-11-09Read the filing on SEC.gov →
- Kiniksa Pharmaceuticals, Ltd. (KNSA)DRS · 2018-02-27Read the filing on SEC.gov →
- Sanofi6-K · 2026-03-03Read the filing on SEC.gov →
- Intellia Therapeutics, Inc. (NTLA)8-K · 2022-02-28Read the filing on SEC.gov →
- REGENERON PHARMACEUTICALS INC (REGN)8-K · 2019-01-07Read the filing on SEC.gov →
- Sanofi6-K · 2025-11-18Read the filing on SEC.gov →
- Sanofi6-K · 2023-01-17Read the filing on SEC.gov →
- REGENERON PHARMACEUTICALS INC (REGN)10-Q · 2003-11-12Read the filing on SEC.gov →
- Sanofi6-K · 2021-12-15Read the filing on SEC.gov →
- Decibel Therapeutics, Inc.SC14D9C · 2023-08-09Read the filing on SEC.gov →
Source: the SEC’s own EDGAR full-text index, which covers filings from 2001onward. Results are ordered by EDGAR’s relevance. A filing appearing here means the phrase is in the document, nothing more. EDGAR caps its match count at 10,000 and reports anything above that as a lower bound, so the figure above is a floor rather than an exact total.